The FDA is hard at work on a variety of drug safety issues. Stay tuned.
You are here
P&T® Journal contents for March 2005
The authors review the reasons why drug importation is still prohibited.
Dr. Goldenberg explains some of the high-tech and low-tech initiatives being undertaken by the FDA to improve drug safety for consumers.
As members of The Drug Shortage Team, the authors describe the causes of and some solutions to drug shortfalls.
The newly created Drug Safety Oversight Board is a step in the right direction.
The authors summarize the responses of participants at two roundtable discussions, held in 2004, to a new decision-analytic model of SRIs.
The skills of pharmacy students can be useful in preventing errors in the areas of clinical appropriateness, administration, ordering, procedures, and dispensing.